SLAM
RVMD icon

Swiss Life Asset Management’s Revolution Medicines RVMD Stock Holding History

Swiss Life Asset Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.32M Buy
17,736
+4,957
+39% +$724K 0.01% 520
2026
Q1 		$1.24M Buy
12,779
+6,056
+90% +$612K 0.01% 620
2025
Q4 		$535K Buy
6,723
+443
+7% +$29K ﹤0.01% 773
2025
Q3 		$293K Buy
+6,280
New +$246K ﹤0.01% 924

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Swiss Life Asset Management's RVMD Position: Q2 2026 in Review

Swiss Life Asset Management increased its Revolution Medicines (RVMD) stake by 39% in Q2 2026, buying an estimated $724K and bringing the position to 17,736 shares worth $3.32M. The position accounts for 0.01% of the portfolio, ranked #520.

Swiss Life Asset Management first reported a position in RVMD in Q3 2025 and has held it in 4 quarters since. 484 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Swiss Life Asset Management held 17,736 shares of Revolution Medicines worth $3.32M as of Q2 2026.
  • Swiss Life Asset Management bought 4,957 Revolution Medicines shares in Q2 2026, an estimated $724K.
  • Revolution Medicines made up 0.01% of Swiss Life Asset Management's portfolio in Q2 2026, its #520 holding.
  • Swiss Life Asset Management first reported a position in Revolution Medicines in Q3 2025 and has held it in 4 quarters since.
  • 484 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.